Xi'an ruixi Biological Technology Co

Home > Keywords >

Catalog	name	Description	price
R-R-2881	PACAP (1-38), amide, Biotin-labeled	PACAP (1-38), amide, Biotin-labeled is a biological active peptide. (Biotin-labeled HY-P0221)	price>
R-C-1182	NS6180	NS6180 is a novel potent and selective KCa3.1 channel inhibitor(IC50=9nM) prevents T-cell activation and inflammation.	price>
R-R-2882	PA-9 CAS No.1436004-46-4	PA-9/CAS No.1436004-46-4 is a pituitary adenylate cyclase-activating polypeptide (PACAP) type I (PAC1) receptor antagonist. PA-9 dose dependently inhibits PACAP-induced cAMP elevation with an IC50 of 5.6 nM. PA-9 can be used for the research of neuropathic and/or inflammatory pain.	price>
R-C-1183	Loxiglumide CAS:107097-80-3	Loxiglumide is a potent,orally active,and selective CCK-A receptor antagonist which stimulates calorie intake and hunger feelings in humans.Loxiglumide inhibits pancreatic secretion of digestive enzymes,and also blocks CCK-induced gastric secretions and emptying.Intravenous administration of loxiglumide antagonized the CCK-induced reduction of gastric emptying in rats,acceleration of intestinal transport in mice,increase in ileal motility in rabbits, gallbladder contraction in guinea pigs and acceleration of gallbladder emptying in mice.	price>
R-R-2883	(Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat) CAS No.213779-11-4	(Tyr36)-pTH-Related Protein (1-36) (human, mouse, rat)/CAS No.213779-11-4 is a peptide and can be used as a parathyroid hormone (PTH) receptor ligand.	price>
R-C-1184	BD1047.2HBr CAS 138356-21-5	BD-1047 hydrobromide,a selective functional antagonist of sigma receptors,has antipsychotic activity in animal models predictive of efficacy in schizophrenia.	price>
R-R-2884	Human PTHrP-(1-36) CAS No.172867-62-8	Human PTHrP-(1-36)/CAS No.172867-62-8 is a secretory form of PTHrP with anticalciuric effects. Human PTHrP-(1-36) enhances beta cell function and proliferation. Human PTHrP-(1-36) can be used in the research of humoral hypercalcemia of malignancy (HHM) and hyperparathyroidism.	price>
R-C-1185	Evacetrapib (LY2484595) CAS No. 1186486-62-3	Evacetrapib is a potent and selective of CETP inhibitor,which inhibits human recombinant CETP protein(IC50 5.5 nM)and CETP activity in human plasma(IC50 36 nM)in vitro.	price>
R-R-2885	Secretin (33-59), rat TFA	Secretin (33-59), rat (TFA) is a 27-aa peptide, which acts on secretin receptor, and enhances the secretion of bicarbonate, enzymes, and K+ from the pancreas.	price>
R-C-1186	TAE226 (NVP-TAE226) CAS:761437-28-9	NVP-TAE 226(TAE226)is a potent and ATP-competitive dual FAK and IGF-1R inhibitor with IC50s of 5.5 nM and 140 nM,respectively.NVP-TAE 226(TAE226) also effectively inhibits Pyk2 and insulin receptor(InsR)with IC50s of 3.5 nM and 44 nM,respectively.	price>
R-R-2886	NKH477 CAS No.138605-00-2	NKH477 (Colforsin dapropate hydrochloride)/CAS No.138605-00-2 directly activates the catalytic unit of adenylate cyclase and increases intracellular cAMP. NKH477 is a forskolin derivative that improves cardiac failure mainly through its beneficial effects on diastolic cardiac function. NKH477 exerts an antiproliferative effect in vivo with an altered cytokine profile to inhibit the acute rejection of rat orthotopic lung allografts.	price>
R-C-1187	SR9243 CAS :1613028-81-1	SR9243 is a potent and selective LXR inverse agonist.SR9243 kills cancer cells by inhibiting lipid production and the Warburg effect.It induces cell death in multiple types of cancer and does not cause the side effects that have derailed previous attempts to target these processes.	price>
R-R-2887	KH7 CAS No.330676-02-3	KH7/CAS No.330676-02-3 is a specific double adenyl cyclone (sAC) inhibitor, with IC50s of 3-10 μM toward both purified human sACT recombinant proteins and highly expressed sACT terolog in cellular assays KH7 is also a cAMP inhibitor	price>
R-C-1188	SB742457 CAS: 607742-69-8	Intepirdine,also known as SB-742457 and RVT-101,is a selective 5-HT6 receptor antagonist with potential cognition,memory,and learning-enhancing effects.It was under development by GlaxoSmithKline for the treatment of Alzheimer is disease and demonstrated some preliminary efficacy in phase II clinical trials.SB742457 can reverse age-related declines in delayed non-match-to-sample performance (DNMS).SB742457 shows increasing pro-cognitive effects in patients with AD.	price>
R-R-2888	LRE1 CAS No.1252362-53-0	LRE1/CAS No.1252362-53-0 is a specific and allosteric inhibitor of soluble adenylyl cyclase.	price>
R-C-1189	ITD-1 CAS:1099644-42-4	ITD-1 is a selective inhibitor of TGF-β signaling (IC50=0.85μM);displays little or no inhibition of activin,Wnt or BMP signaling pathways.ITD-1 selectively enhanced the differentiation of uncommitted mesoderm to cardiomyocytes,but not to vascular smooth muscle and endothelial cells.ITD-1 is a highly selective TGF-β inhibitor and reveals an unexpected role for TGF-β signaling in controlling cardiomyocyte differentiation from multipotent cardiovascular precursors.	price>
R-R-2889	TDI-10229 CAS No.2810887-45-5	TDI-10229/CAS No.2810887-45-5 is a potent and orally bioavailable inhibitor of soluble adenylyl cyclase (sAC, ADCY10). TDI-10229 displays nanomolar inhibition of sAC in both biochemical and cellular assays (IC50 of 195 nM) and exhibits mouse pharmacokinetic properties sufficient to warrant its use as an in vivo tool compound.	price>
R-C-1190	LRRK2-IN-1 CAS:1234480-84-2	LRRK2-IN-1 is a potent and selective LRRK2 inhibitor with IC50 of 6 nM and 13 nM for LRRK2(G2019S)and LRRK2(WT),respectively.	price>
R-R-2890	Fipexide CAS No.34161-24-5	Fipexide/CAS No.34161-24-5, a parachloro-phenossiacetic acid derivative, is an orally active nootropic agent. Fipexide reduces striatal adenylate cyclase activity. Fipexide has positive effect on cognitive performance by dopaminergic neurotransmission. Fipexide is used for senile dementia research. Fipexide acts as a chemical inducer in callus formation, shoot regeneration and Agrobacterium infection.	price>
R-C-1191	CP465022HCl CAS:199655-36-2	CP-465022 is a potent,and selective noncompetitive AMPA receptor antagonist.It provides neuroprotective efficacy after cerebral ischemia on the basis of the activity in experimental ischemia models.	price>

496497498499500501 502503504505506